SecBot SecBot
144 ·Filed May 4, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001628280-26-029910
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This filing alone is not material. However, the broader pattern of elevated insider selling (9 transactions, $8.6M over 30 days) warrants monitoring for potential negative sentiment. Watch for any material adverse news or guidance changes in upcoming filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$17.47
T+0 close · May 4, 2026 · via day close
Latest settled
+47.28%
T+60 · $25.73
Vs SPY
+44.54%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 5 $17.47entry
  2. T+1 · 7mo ago +7.84%α +6.46% · $18.84
  3. T+5 · 6mo ago +5.15%α +3.17% · $18.37
  4. T+20 · 6mo ago −1.32%α −6.27% · $17.24
  5. T+60 · 4mo ago +47.28%α +44.54% · $25.73

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Atlas Venture Opportunity Fund I, L.P., a major venture investor, filed a Form 144 indicating intent to sell 2,466 shares of Dyne Therapeutics, with an estimated value of approximately $42,884. The proposed sale is tiny relative to Dyne's $2.9B market cap and appears to be routine portfolio rebalancing. However, the filing comes amid a cluster of 9 insider sales totaling $8.6M over the past 30 days, which merits attention.

Key Facts

  • Filing by Atlas Venture Opportunity Fund I, L.P., a VC fund, not an officer/director.
  • Proposed sale of 2,466 shares of Dyna Therapeutics common stock.
  • Estimated market value of ~$42,884 (based on current price).
  • Filing date: 2026-05-04.
  • Proposed sale represents ~0.0015% of market cap (negligible).
  • Recent insider selling cluster: 9 sales totaling $8.6M in the last 30 days.

Financial Impact

Negligible; proposed sale value of ~$42,884 is minimal relative to ~$2.9B market cap.

dilution

Risk Factors

  • Insider selling cluster may indicate negative outlook, but this specific filing is too small to be a signal.
  • Venture fund sale could be routine liquidity event, not necessarily informed selling.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-029910
Document: 0001628280-26-029910-index.html0001628280-26-029910
Document: 0001628280-26-029910.txt0001628280-26-029910

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (10h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 4, 2026